277 related articles for article (PubMed ID: 28814801)
41. Electroclinical characteristics of seizures-comparing Prader--Willi syndrome with Angelman syndrome.
Wang PJ; Hou JW; Sue WC; Lee WT
Brain Dev; 2005 Mar; 27(2):101-7. PubMed ID: 15668048
[TBL] [Abstract][Full Text] [Related]
42. Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the
Syding LA; Kubik-Zahorodna A; Nickl P; Novosadova V; Kopkanova J; Kasparek P; Prochazka J; Sedlacek R
Cells; 2022 Sep; 11(18):. PubMed ID: 36139390
[TBL] [Abstract][Full Text] [Related]
43. Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.
Dodge A; Peters MM; Greene HE; Dietrick C; Botelho R; Chung D; Willman J; Nenninger AW; Ciarlone S; Kamath SG; Houdek P; Sumová A; Anderson AE; Dindot SV; Berg EL; O'Geen H; Segal DJ; Silverman JL; Weeber EJ; Nash KR
Autism Res; 2020 Mar; 13(3):397-409. PubMed ID: 31961493
[TBL] [Abstract][Full Text] [Related]
44. Replicable in vivo physiological and behavioral phenotypes of the
Dhamne SC; Silverman JL; Super CE; Lammers SHT; Hameed MQ; Modi ME; Copping NA; Pride MC; Smith DG; Rotenberg A; Crawley JN; Sahin M
Mol Autism; 2017; 8():26. PubMed ID: 28638591
[TBL] [Abstract][Full Text] [Related]
45. Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice.
Sell GL; Xin W; Cook EK; Zbinden MA; Schaffer TB; O'Meally RN; Cole RN; Margolis SS
Sci Rep; 2021 Sep; 11(1):19414. PubMed ID: 34593829
[TBL] [Abstract][Full Text] [Related]
46. Understanding the pathogenesis of Angelman syndrome through animal models.
Jana NR
Neural Plast; 2012; 2012():710943. PubMed ID: 22830052
[TBL] [Abstract][Full Text] [Related]
47. Angelman syndrome reviewed from a neurophysiological perspective. The UBE3A-GABRB3 hypothesis.
Dan B; Boyd SG
Neuropediatrics; 2003 Aug; 34(4):169-76. PubMed ID: 12973656
[TBL] [Abstract][Full Text] [Related]
48. Spatial and temporal silencing of the human maternal UBE3A gene.
Daily J; Smith AG; Weeber EJ
Eur J Paediatr Neurol; 2012 Nov; 16(6):587-91. PubMed ID: 22560727
[TBL] [Abstract][Full Text] [Related]
49. Episodic tremors representing cortical myoclonus are characteristic in Angelman syndrome due to UBE3A mutations.
Goto M; Saito Y; Honda R; Saito T; Sugai K; Matsuda Y; Miyatake C; Takeshita E; Ishiyama A; Komaki H; Nakagawa E; Sasaki M; Uto C; Kikuchi K; Motoki T; Saitoh S
Brain Dev; 2015 Feb; 37(2):216-22. PubMed ID: 24796722
[TBL] [Abstract][Full Text] [Related]
50. Recovery of Angelman syndrome rat deficits with UBE3A protein supplementation.
Dodge A; Morrill NK; Weeber EJ; Nash KR
Mol Cell Neurosci; 2022 May; 120():103724. PubMed ID: 35367589
[TBL] [Abstract][Full Text] [Related]
51. Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities.
Leach PT; Crawley JN
Genes Brain Behav; 2018 Jul; 17(6):e12452. PubMed ID: 29266714
[TBL] [Abstract][Full Text] [Related]
52. Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome.
Berg EL; Pride MC; Petkova SP; Lee RD; Copping NA; Shen Y; Adhikari A; Fenton TA; Pedersen LR; Noakes LS; Nieman BJ; Lerch JP; Harris S; Born HA; Peters MM; Deng P; Cameron DL; Fink KD; Beitnere U; O'Geen H; Anderson AE; Dindot SV; Nash KR; Weeber EJ; Wöhr M; Ellegood J; Segal DJ; Silverman JL
Transl Psychiatry; 2020 Jan; 10(1):39. PubMed ID: 32066685
[TBL] [Abstract][Full Text] [Related]
53. Region-specific impairments in striatal synaptic transmission and impaired instrumental learning in a mouse model of Angelman syndrome.
Hayrapetyan V; Castro S; Sukharnikova T; Yu C; Cao X; Jiang YH; Yin HH
Eur J Neurosci; 2014 Mar; 39(6):1018-1025. PubMed ID: 24329862
[TBL] [Abstract][Full Text] [Related]
54. Genetically Dissecting Cortical Neurons Involved in Epilepsy in Angelman Syndrome.
Santini E; Klann E
Neuron; 2016 Apr; 90(1):1-3. PubMed ID: 27054611
[TBL] [Abstract][Full Text] [Related]
55. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
[TBL] [Abstract][Full Text] [Related]
56. Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome.
Riday TT; Dankoski EC; Krouse MC; Fish EW; Walsh PL; Han JE; Hodge CW; Wightman RM; Philpot BD; Malanga CJ
J Clin Invest; 2012 Dec; 122(12):4544-54. PubMed ID: 23143301
[TBL] [Abstract][Full Text] [Related]
57. Electrophysiological Phenotype in Angelman Syndrome Differs Between Genotypes.
Frohlich J; Miller MT; Bird LM; Garces P; Purtell H; Hoener MC; Philpot BD; Sidorov MS; Tan WH; Hernandez MC; Rotenberg A; Jeste SS; Krishnan M; Khwaja O; Hipp JF
Biol Psychiatry; 2019 May; 85(9):752-759. PubMed ID: 30826071
[TBL] [Abstract][Full Text] [Related]
58. Maternal Loss of Ube3a Impairs Experience-Driven Dendritic Spine Maintenance in the Developing Visual Cortex.
Kim H; Kunz PA; Mooney R; Philpot BD; Smith SL
J Neurosci; 2016 Apr; 36(17):4888-94. PubMed ID: 27122043
[TBL] [Abstract][Full Text] [Related]
59. Altered serotonin, dopamine and norepinepherine levels in 15q duplication and Angelman syndrome mouse models.
Farook MF; DeCuypere M; Hyland K; Takumi T; LeDoux MS; Reiter LT
PLoS One; 2012; 7(8):e43030. PubMed ID: 22916201
[TBL] [Abstract][Full Text] [Related]
60. Angelman Syndrome due to a Maternally Inherited Intragenic Deletion Encompassing Exons 7 and 8 of the UBE3A Gene.
Ververi A; Islam L; Bewes B; Busby L; Sullivan C; Canham N
Cytogenet Genome Res; 2017; 152(3):132-136. PubMed ID: 28898887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
